As global clinical trial activity continues to normalize from peak pandemic levels, the pharma industry is seeking to improve the efficiency of how such studies are conducted. As a result, competition between both countries and individual sites within these is intensifying.
Korea Can Play To Strengths But Also Improve Regulatory Flexibility For Clinical Trials
Rising Up Ranks Of Study Locations
A session at the recent KoNECT conference in Seoul looked at Korea’s strengths in clinical trials but also at what's needed to further improve its global competitiveness as a location for studies.
